A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities
Clinical trial NCT03639987 · TERMINATED
Trial details
- NCT number
- NCT03639987
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2019-07-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.